Patient info Search Menu

Volibris 10 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
10 mg
Contains active substance:

Patient leaflet - Volibris 10 mg film-coated tablets

1 What Volibris is and what it is used for

➔ Don’t breast-feed while you’re taking

These tablets come in special packaging to prevent children removing them.

Volibris. Talk to your doctor about this.

  • liver problems

2 What you need to know before you take Volibris

Other medicines and Volibris

  • anaemia (a reduced number of red

    1. 1. Separate one tablet: tear along

Tell your doctor or pharmacist if you’re taking, have recently taken or might take any other medicines.

blood cells)

the cutting lines to separate one “pocket” from the strip.

Fertility

3 How to take Volibris

  • swelling in the hands, ankles or feet

    If you are a man taking Volibris, it is possible that this medicine may lower your sperm count. Talk to your doctor if you have any questions or concerns about this.

4 Possible side effects

caused by fluid (peripheral oedema)

  1. 3.

    Push out the tablet: gently push one

    Your doctor may need to adjust your dose of Volibris if you start taking cyclosporine A (a medicine used after transplant or to treat psoriasis). If you’re taking rifampicin (an antibiotic used to treat serious infections) your doctor will monitor you when you first start taking Volibris.

5 How to store Volibris

  • lung disease where the veins in

    the lungs are blocked (pulmonary veno-occlusive disease).

6 Contents of the pack and other information

➔ Your doctor will decide whether

Driving and using machines

Volibris is suitable for you.

Volibris may cause side effects, such as low blood pressure, dizziness, tiredness (see section 4), that may affect your ability to drive or use machines. The symptoms of your condition can also make you less fit to drive or use machines.

You will need regular blood tests

  1. 2. Peel back the outer layer: starting at

Before you start taking Volibris, and at regular intervals while you’re taking it, your doctor will take blood tests to check:

the coloured corner, lift and peel over the pocket.

If you’re taking other medicines used to treat PAH (e.g. iloprost, epoprostenol, sildenafil) your doctor may need to monitor you.

  • whether you have anaemia

    ➔ Don’t drive or use machines if you’re feeling unwell.

    ➔ Tell your doctor or pharmacist if you

  • whether your liver is working

    are taking any of these medicines.

    properly.

    Pregnancy

➔ It is important that you have these

regular blood tests for as long as you are taking Volibris.

Volibris may harm unborn babies conceived before, during or soon after treatment.

4 Possible side effects

6 Contents of the pack and

Authorisation Holder:

other information

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Other side effects include

Uncommon side effects:

What Volibris contains

United Kingdom

end of the tablet through the foil layer.

GlaxoSmithKline UK Ltd

  • liver injury

    The active substance is ambrisentan. Each film-coated tablet contains 5 or 10 mg.

Very common side effects:

Tel: + 44 (0)800 221441

  • inflammation of the liver caused

    customercontactuk@gsk.com

  • headache

Conditions you and your doctor need to look out for:

by the body’s own defences (autoimmune hepatitis)

  • dizziness

    The other ingredients are: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc (E553b), titanium dioxide (E171), macrogol 3350, lecithin (soya) (E322) and Allura red AC Aluminium Lake (E129).

    This leaflet was last revised in 10/2018 Other sources of information

  • palpitations (fast or irregular heart

Allergic reactions

In combination with tadalafil

beats)

This is a common side effect that may affect up to one in 10 people. You may notice a rash or itching and swelling (usually of the face, lips, tongue or throat), which may cause difficulty in breathing or swallowing

  • sudden hearing loss.
  • worsening shortness of breath shortly

    after starting Volibris

    Reporting of side effects

  • a runny or blocked nose, congestion

    If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

If you take more Volibris than you should

or pain in the sinuses

What Volibris looks like and contents of the pack

  • feeling sick (nausea)

If you take too many tablets you may be more likely to have side effects, such as headache, flushing, dizziness, nausea (feeling sick), or low blood pressure that could cause light-headedness:

Swelling (oedema), especially of the ankles and feet

  • diarrhoea

    Volibris 5 mg film-coated tablet (tablet) is a pale pink, square, convex tablet engraved with ‘GS’ on one face and ‘K2C’ on the other.

  • feeling tired

This is a very common side effect that may affect more than one in 10 people

In combination with tadalafil (another PAH medicine)

➔ Ask your doctor or pharmacist for

Heart failure

Volibris 10 mg film-coated tablet (tablet) is a deep pink, oval, convex tablet engraved with ‘GS’ on one face and ‘KE3’ on the other.

In addition to the above:

advice if you take more tablets than prescribed.

This is due to the heart not pumping out enough blood, causing shortness of breath, extreme tiredness and swelling in the ankles and legs. This is a common side effect that may affect up to one in 10 people

  • flushing (redness of the skin)

    5 How to store Volibris

  • being sick (vomiting)

If you forget to take Volibris

Volibris is supplied as 5 mg and 10 mg film-coated tablets in unit dose blister packs of 10x1 or

  • chest pain/discomfort.

If you forget a dose of Volibris, just take the tablet as soon as you remember, then carry on as before.

Keep this medicine out of the sight and reach of children.

Common side effects:

30x1 tablets.

Anaemia (reduced number of red blood cells)

  • blurry or other changes to vision

➔ Don’t take two doses at the same time to make up for a forgotten dose.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.

Not all pack sizes may be marketed.

  • fainting

    Marketing Authorisation Holder

This is a blood disorder which can cause tiredness, weakness, shortness of breath, and generally feeling unwell. Sometimes this requires a blood transfusion. This is a very common side effect that may affect more than one in 10 people

  • abnormal blood test results for liver

    GlaxoSmithKline (Ireland) Limited 12 Riverwalk

    The expiry date refers to the last day of that month.

    function

Don’t stop taking Volibris without your doctor’s advice

  • a runny nose

    Citywest Business Campus

    This medicine does not require any special storage conditions.

    Dublin 24

Volibris is a treatment that you will need to keep on taking to control your PAH. ➔ Don’t stop taking Volibris unless you

  • constipation

    Ireland

  • pain in your stomach (abdomen)

    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

    Manufacturer

Hypotension (low blood pressure)

  • chest pain or discomfort

have agreed this with your doctor.

Glaxo Operations UK Ltd

This can cause light-headedness. This is a common side effect that may affect up to one in 10 people

(trading as GlaxoWellcome Operations) Harmire Road

  • flushing (redness of the skin)

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

  • being sick (vomiting)

    Barnard Castle

➔ Tell your doctor straight away if you

  • feeling weak

    Co. Durham DL12 8DT

get these effects or if they happen suddenly after taking Volibris. It is important to have regular blood tests, to check for anaemia and that your liver is working properly. Make sure that you have also read the information in section 2 under ‘You will need regular blood tests’ and ‘Signs that your liver may not be working properly’.

United Kingdom

  • nose bleed
  • rash

In combination with tadalafil

In addition to the above, except abnormal blood test results for liver function:

  • ringing in the ears (tinnitus) only when

    taking the combination treatment.

    2800004589

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: October 2018

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Volibris 10 mg film-coated tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Ambrisentan
Strength? 10 mg
Pharmaceutical form? Oral tablet
Deep-pink, 9.8 mm × 4.9 mm oval, convex, film-coated tablet with “GS” debossed on one side and “KE3” on the other side.
How is it taken? Oral
Excipients? Lactose monohydrate, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Polyvinyl alcohol, Talc, Titanium dioxide (E171), Macrogol, Lecithin (soya) (E322), Allura red AC aluminium lake (E129)
Pack sizes 30 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 5 years.
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC)? Anti-hypertensives, other anti-hypertensives
  1. C Cardiovascular system drugs
    1. C02 Antihypertensives
      1. C02K Other antihypertensives
        1. C02KX Antihypertensives for pulmonary arterial hypertension
          1. C02KX02 ambrisentan
Marketing authorisation? PLGB 19494/0281 (first authorised 1 January 2021)
Marketing authorisation holder? GlaxoSmithKline UK Limited
Codes? GTIN 5000123115280 · BNF 02050100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.2.0 of 16 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.